C63S (p.Cys63Ser) variant of KRT14 (Keratin, type I cytoskeletal 14)

C63S (p.Cys63Ser) in KRT14 (Keratin, type I cytoskeletal 14) is a missense change. Clinical records from EBI and UniProt describe it as benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.14 / 1. The record also includes population frequency data and structural context.

C63S (p.Cys63Ser) variant details